Revenue: As of FY2025 Q1, the actual value is USD 2.407 M.EPS: As of FY2025 Q1, the actual value is USD -0.16.EBIT: As of FY2025 Q1, the actual value is USD -1.779 M.<h3>Segment Revenue</h3><ul><li>Benchtop Laboratory Equipment: Revenue for the three months ended March 31, 2025, was $2,273,000, compared to $2,167,400 for the same period in 2024.</li><li>Bioprocessing Systems: Revenue for the three months ended March 31, 2025, was $133,500, compared to $316,100 for the same period in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Loss: The net loss for the three months ended March 31, 2025, was -$1,778,500, compared to -$2,051,600 for the same period in 2024.</li><li>Gross Profit: Gross profit for the three months ended March 31, 2025, was $1,016,600, compared to $1,040,800 for the same period in 2024.</li><li>Operating Expenses: Total operating expenses for the three months ended March 31, 2025, were $2,827,500, compared to $3,130,300 for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: Net cash used in operating activities for the three months ended March 31, 2025, was -$1,331,100, compared to -$1,565,100 for the same period in 2024.</li><li>Investing Cash Flow: Net cash provided by investing activities for the three months ended March 31, 2025, was $1,204,000, compared to $480,600 for the same period in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Foreign Sales: Foreign sales for the three months ended March 31, 2025, were $577,200, compared to $855,600 for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue cost-cutting initiatives in the Bioprocessing Systems Operations segment, which were initiated in fiscal 2024.</li><li>Non-Core Business: The company is exploring the sale of assets and securing additional capital resources to address liquidity concerns.</li></ul>

Scientific Industries, Inc. | 10-Q: FY2025 Q1 Revenue: USD 2.407 M